With a record 59 new drugs approved by the FDA and 42 new active substances recommended for authorization by the European Medicines Agency, 2018 was a profoundly productive year for biopharma. In a new analysis, Jamie Munro and Helen Dowden from Clarivate Analytics examine whether 2018 represents “a fleeting success” or if there are underlying […]
The latest Global Research Report: G20 scorecards
Against a current backdrop of tensions in international trade – the Brexit quandary and the tariff duels initiated by US President Donald Trump being just two examples – the Institute for Scientific Information (ISI) of the Web of Science Group™ weighs in with a timely subject for its fourth Global Research Report: a collection of […]
Announcing the 2019 Journal Citation Reports
On June 20, the Web of Science Group™, a Clarivate Analytics company, released the 2019 Journal Citation Reports (JCR). This latest release extends the run of an annual event that stretches back nearly a half century. In that time, the JCR has evolved, with its measurements for journal evaluation refined, expanded and elucidated. This year […]
Biopharma mega mergers remain a force: Q1 analysis
During the first quarter of 2019, Cortellis Deals Intelligence registered 124 new mergers and acquisitions (M&A), a 24% increase from 100, quarter on quarter vs. last year, as part of its ongoing coverage of M&A activity in the life sciences sector (see Figure 1). However, total disclosed deal value declined by 9% to $119.2 billion […]
Empowering women
The share of female CEOs of Fortune 500 companies reached an all-time high of 6.4% in 2017, with 32 women heading major firms. But the share fell to 4.8% in 2018 after several high-profile women left their posts.[1] In the U.S., women represent 47% of the workforce, yet they hold just 21% of senior leadership […]
Introducing Publisher Analytics Reports: Track Performance of Papers, Evaluate the Competition, and Spot Opportunities
For academic publishers in search of detailed metrics on how their papers are performing, or in need of insights into the competition and how best to strategize their efforts, the Web of Science Group™ has now delivered the answer. A quartet of new Publisher Analytics Reports provides comprehensive, ready-to-use data on key aspects of journal […]
Potential blockbusters make a splash on market entry
Potential blockbusters make a splash on market entry Earlier this year, the Cortellis Drugs to Watch 2019 report highlighted seven drugs predicted to launch in 2019 and achieve blockbuster status by 2023. By the mid-point of the year, Zolgensma has entered the market as the most expensive drug ever launched, Skyrizi has been approved and […]
Oncology, dermatology, hematology pace Q1 biopharma licensing
During the first quarter of 2019, Cortellis Deals Intelligence registered 1,023 new deals (excluding mergers & acquisitions) as part of its ongoing coverage of licensing activity in the life sciences sector, a minor decrease of 0.6% from 1,029 in Q1 a year ago. The total disclosed deal value rose to $44.9 billion, a 26.8% rise […]
Medtronic drives innovation, eyeing new products to stay on top
BioWorld MedTech™, the global medical device news service from Clarivate Analytics, developed a series of articles on how key companies in the industry approach innovation. Below is an excerpt from the profile of Medtronic plc. Click here to access to the full series. Medtronic plc is the largest pure-play med-tech company in the world by […]
A Researcher’s Complete Guide to Open Access Papers
Finding quality scientific research can be hard, even in the Information Age when almost anything can be found online. Open access papers make the research process just that little bit easier. This blog will provide researchers with a full overview of what open access is, the advantages of open access resources, what to look out […]
